We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Faces Swelling MDL Over Bextra, Celebrex

Law360 (September 12, 2007, 12:00 AM EDT) -- Thirty civil actions from various district courts have flooded in to the California federal court presiding over the multidistrict litigation against Pfizer Inc. concerning the alleged health risks associated with the drug maker's anti-inflammatory drugs Bextra and Celebrex.

Despite the rash of dismissals from the multidistrict litigation, 30 cases were transferred earlier this month to the U.S. District Court for the Northern District of California for coordinated or consolidating pretrial proceedings, bringing the total number of transferred actions to 1,140 suits as of Sept. 6, according...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.